MedPath

Simulated Walking With Multiplexing Prism for Field Expansion in Monocular Vision

Not Applicable
Terminated
Conditions
Blind Right Eye
Blind Left Eye
One Eye Blindness
Interventions
Device: Multiplexing Prism
Registration Number
NCT06024668
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Brief Summary

The investigators are developing an assistive device, known as multiplexing prism that expands the field of view for individuals with acquired monocular vision (loss of an eye). The investigators will test the efficacy of the prism in improving the detection of colliding pedestrians during a simulated walking task.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1
Inclusion Criteria
  • No medical health issues such as seizures, motor movements problem
  • Loss of vision in one eye (less than 20/200) for >1 year
  • Visual acuity of the seeing eye: Better than 20/32 visual acuity with correction
  • No visual field defect in the seeing eye (nasal field of at least >45degree)
Exclusion Criteria
  • Patients with any physical or mental disabilities, including cognitive dysfunction, balance problems, or other deficits that could impair their ability to respond to the stimuli presented in this study will be excluded
  • Any person with a history (such as pacemaker use or photosensitive epilepsy)
  • Any person with motor movements problem (e.g., unable to use extremities)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Detection of colliding pedestrianMultiplexing PrismParticipants will perform a simulated walking task in which surrounding pedestrians will walk towards and make a collision. Participants will respond by pressing buttons to indicate the direction of the colliding pedestrians. Participants will perform the task with and without the multiplexing prism in random orders.
Primary Outcome Measures
NameTimeMethod
Mean response time to detect colliding pedestrianApproximately 3 sessions, up to 3 hours for each session, any time within 4 month period

The investigators will compare the mean response time to detect colliding pedestrians coming from the nasal (same side as the blind eye) and temporal (same side as the seeing eye) visual field with and without multiplexing prism. The comparison will be made between these four: Nasal without prism, Temporal without prism, Nasal with prism, and Temporal with prism.

Secondary Outcome Measures
NameTimeMethod
Pedestrian Detection RateApproximately 3 sessions, up to 3 hours for each session, any time within 4 month period

The investigators will measure the rate of correct detection rate of colliding pedestrians in the nasal (same side as the blind eye) and temporal (same side as the seeing eye) with and without multiplexing prism. Comparisons will be made for these: nasal without prism, temporal without prism, nasal with prism,and temporal with prism.

Trial Locations

Locations (1)

Schepens Eye Research Institute

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath